The Effect on Pain and Satisfaction of Two Different Non-Pharmacological Methods Used During Coronavirus (Covid-19) Vaccination
Individual Satisfaction, Pain Management
About this trial
This is an interventional supportive care trial for Individual Satisfaction focused on measuring covid-19, covid-19 vaccine, pain control, nonpharmacological method, satisfaction
Eligibility Criteria
Inclusion Criteria:
- Approving the Pfizer-BioNTech vaccination from the Turkish Ministry of Health
- Not having had an injection or vaccination in the deltoid muscle for at least three months
- Participating voluntarily in the study
- Being able to speak and understand Turkish
- Being aged 18 years or older
- Not having any vision or auditory problems
- Not having any condition which might affect pain sensation
- Not having developed any complication which would hinder a delta muscle injection.
Exclusion Criteria:
- Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study
- Having any condition which would affect the sensation of pain
- Not being able to agree on a place or time
- Being less than 18 years of age
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
The stress ball group
The Buzzy® group
The control group
With this group, a yellow stress ball will be used which is 6cm in diameter, of medium hardness and made of high quality silicone, and which returns to its original shape after being squeezed. The researcher will explain to the individuals in the group how they should use the stress ball five minutes before beginning the vaccination and during the procedure. The individuals will be taught to take the stress ball in their right hand, the side on which the vaccination will not be given, and, counting from one to three, to squeeze and release the ball, continuing until the procedure is finished. It will be explained that during the procedure, they should give their attention to the stress ball and focus on squeezing it.
Individuals in this group will use the Buzzy® device. Before the vaccination procedure, the researcher will place the Buzzy® device, which will be at room temperature, on the vaccination site, and it will vibrate in a non-discomforting way for one minute. After this, the Buzzy® device will be removed from the site, and the nurse will perform the vaccination. Because Buzzy® is a device which can be re-used, it will be disinfected after each vaccination procedure, and re-used with other individuals. The Buzzy® device also has ice wings which will not be used in this study, and only the body of the device will be used to provide vibration.
Individuals included in the control group will receive no intervention before the vaccination procedure, and the routine Covid-19 vaccination procedure will be used.